Cargando…
The use of hypomethylating agents in hematologic malignancies: treatment preferences and results
AIM: The objective of this article was to compare the efficiency of azacitidine (AZA) and decitabine (DAC) in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) who are not suitable for high-dose chemotherapy. MATERIALS AND METHODS: MDS and AML patients who were treated wi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922247/ https://www.ncbi.nlm.nih.gov/pubmed/35295753 http://dx.doi.org/10.2217/ijh-2020-0019 |